Generic placeholder image

Current Drug Safety

Author(s): Ahmed Zaiem*, Syrine Ben Hammamia, Fares Ben Salem, Ons Charfi, Imen Aouinti, Sarrah Kastalli, Sihem El Aidli, Talel Badri, Ghozlane Lakhoua and Habiba Mizouni

DOI: 10.2174/1574886316666210923143012

DownloadDownload PDF Flyer Cite As
Skin Tests for the Exploration of Hypersensitivity Reactions Associated with Iodinated Contrast Media

Page: [169 - 175] Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Background: Iodinated contrast media (ICM) are responsible for multiple side effects, especially hypersensitivity reactions. These reactions can either be authentic allergies or non-allergic hypersensitivity reactions. Skin tests (prick and intradermal tests) are simple to perform and can be of great help, especially if the ICM needs to be re-used. The aim of the study was to assess the characteristics of the patients in whom skin tests were performed and the results of these tests.

Methods: This is a retrospective study from June 2014 to June 2019. All included patients had at least one episode of hypersensitivity reaction to ICM and underwent skin tests.

Results: We included 35 patients aged 18 to 85 years. The iopromide was the most implicated ICM. The reactions were mainly cutaneous (n=30) and immediate (n=27). The skin tests were negative, except for two patients. The re-use of ICM occurred in 11 patients: 9 with an ICM other than the one suspected and two patients with the same ICM. Among these patients, 5 did not have any premedication. Two of them had a second hypersensitivity reaction, the first with another ICM and the second with the same ICM.

Conclusion: One of the main pillars of allergic exploration is ICM skin testing, not only to prevent a recurrence, but also to allow patients to benefit from ICM re-use, which are sometimes essential.

Keywords: Iodinated contrast media, drug hypersensitivity, skin tests, in vivo tests, intradermal tests, prick tests.

[1]
Barbaud A, Lerondeau B, Trechot P, Paris C. Réactions croisées et produits de contraste iodés. Rev Fr Allergol 2015; 55(3): 153-6.
[http://dx.doi.org/10.1016/j.reval.2015.01.039]
[2]
Brockow K. Contrast media hypersensitivity- scope of the problem. Toxicology 2005; 209(2): 189-92.
[http://dx.doi.org/10.1016/j.tox.2004.12.032] [PMID: 15767034]
[3]
Schild HH, Kuhl CK, Hübner-Steiner U, Böhm I, Speck U. Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: A prospective randomized controlled trial. Radiology 2006; 240(1): 56-64.
[http://dx.doi.org/10.1148/radiol.2393050560] [PMID: 16720865]
[4]
Miremont-Salamé G, Théophile H, Haramburu F, Bégaud B. Imputabilité en pharmacovigilance: De la méthode française originelle aux méthodes réactualisées. Therapie 2016; 71(2): 171-8.
[http://dx.doi.org/10.1016/j.therap.2016.02.009] [PMID: 27080836]
[5]
Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1(8009): 466-9.
[http://dx.doi.org/10.1016/S0140-6736(77)91953-5] [PMID: 65572]
[6]
ICH Topic E 6 (R1) Guideline for Good Clinical Practice. Available from:https://www.ema.europa.eu/en/ich-e6-r2-good-clinical-practice Accessed November 28, 2020.
[7]
Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57(1): 45-51.
[PMID: 11991289]
[8]
ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media. 2020. Available from:https://www.acr.org/-/media/ACR/files/clinical-resources/contrast_media.pdf Accessed November 28 2020.
[9]
SFR. CIRTACI.Produits de contraste et Allergie : Hypersensibilité de type immédiat.Fiche de recommandation pour la pratique clinique. 2009. Available from:http://www.sfrnet.org/Data/upload/documents/CIRTACI/Fiche%20Allergie%2029%2009%202009.pdf Accessed November 28 2020.
[10]
Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990; 175(3): 621-8.
[http://dx.doi.org/10.1148/radiology.175.3.2343107] [PMID: 2343107]
[11]
Celik I, Hoppe M, Lorenz W, et al. Randomised study comparing a non-ionic with an ionic contrast medium in patients with malignancies: First answer with a new diagnostic approach. Inflamm Res 1999; 48(Suppl. 1): S47-8.
[http://dx.doi.org/10.1007/s000110050395] [PMID: 10350157]
[12]
Webb JA, Stacul F, Thomsen HS, Morcos SK. Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 2003; 13(1): 181-4.
[http://dx.doi.org/10.1007/s00330-002-1650-5] [PMID: 12541128]
[13]
Morzycki A, Bhatia A, Murphy KJ. Adverse reactions to contrast material: A canadian update. Can Assoc Radiol J 2017; 68(2): 187-93.
[http://dx.doi.org/10.1016/j.carj.2016.05.006] [PMID: 27745988]
[14]
Choyke PL, Miller DL, Lotze MT, Whiteis JM, Ebbitt B, Rosenberg SA. Delayed reactions to contrast media after interleukin-2 immunotherapy. Radiology 1992; 183(1): 111-4.
[http://dx.doi.org/10.1148/radiology.183.1.1549655] [PMID: 1549655]
[15]
Caro JJ, Trindade E, McGregor M. The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: A meta-analysis. AJR Am J Roentgenol 1991; 156(4): 825-32.
[http://dx.doi.org/10.2214/ajr.156.4.1825900] [PMID: 1825900]
[16]
Goksel O, Aydın O, Atasoy C, et al. Hypersensitivity reactions to contrast media: Prevalence, risk factors and the role of skin tests in diagnosis- a cross-sectional survey. Int Arch Allergy Immunol 2011; 155(3): 297-305.
[http://dx.doi.org/10.1159/000320760] [PMID: 21293150]
[17]
Seong JM, Choi NK, Lee J, et al. Comparison of the safety of seven iodinated contrast media. J Korean Med Sci 2013; 28(12): 1703-10.
[http://dx.doi.org/10.3346/jkms.2013.28.12.1703] [PMID: 24339697]
[18]
Yoon SH, Lee SY, Kang HR, et al. Skin tests in patients with hypersensitivity reaction to iodinated contrast media: A meta-analysis. Allergy 2015; 70(6): 625-37.
[http://dx.doi.org/10.1111/all.12589] [PMID: 25649510]
[19]
Liccardi G, D’Amato G, Canonica GW, Salzillo A, Piccolo A, Passalacqua G. Systemic reactions from skin testing: Literature review. J Investig Allergol Clin Immunol 2006; 16(2): 75-8.
[PMID: 16689179]
[20]
Schrijvers R, Breynaert C, Ahmedali Y, Bourrain JL, Demoly P, Chiriac AM. Skin testing for suspected iodinated contrast media hypersensitivity. J Allergy Clin Immunol Pract 2018; 6(4): 1246-54.
[http://dx.doi.org/10.1016/j.jaip.2017.10.040] [PMID: 29371073]
[21]
Brockow K, Romano A, Aberer W, et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study. Allergy 2009; 64(2): 234-41.
[http://dx.doi.org/10.1111/j.1398-9995.2008.01832.x] [PMID: 19178403]
[22]
Contrast Media. Safety Issues and ESUR Guidlines.Springer-Verlag Berlin Heidelberg. Thomsen SH, Webb JAW, Eds. 2009.
[23]
Tramèr MR, von Elm E, Loubeyre P, Hauser C. Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: Systematic review. BMJ 2006; 333(7570): 675.
[http://dx.doi.org/10.1136/bmj.38905.634132.AE] [PMID: 16880193]